The clinical success of CRISPR-based treatments is fundamentally dependent on sophisticated gRNA targeting systems that ...
NYB Partnered with Nvidia, HP and Equinix to Build the World's Largest Natural Compound Library for AI Drug Discovery ...
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, and Hemispherian AS, a Norwegian ...
When a key protein regulator dials down DNA repair mechanisms, our cells accumulate more mutations, which may cause us to age ...
A new study in fruit flies describes how an animal's gut reacts differently to beneficial microbes versus harmful pathogens.
On October 2nd, 2025, NYB announced that it entered into a business combination agreement ("BCA") with RF Acquisition Corp II ("RFAI") (NASDAQ: RFAI), a publicly traded special purpose acquisition ...
Every new life begins after a genetic shuffle. When organisms make eggs or sperm, maternal and paternal chromosomes pair up ...
Junk DNA” may hold the key to treating tough cancers. Existing drugs exploit weaknesses in cells with gene mutations. Researchers at King’s College London have identified a promising strategy for ...
Some leading organizations in the field of cell and gene therapies recently issued a call for a 10-year international moratorium delay on the use of CRISPR. That's the scissoring techniques used to ...
ST. PETERSBURG, Fla. — UPDATE: The St. Pete City Council unanimously agreed Thursday to spend more money on repairs to Tropicana Field. They have signed off on nearly $1 million of work, with most of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback